Based on the results of the DISCOVER-2 Trial (McInnes et al., PMID 34719872), should guselkumab be used prior to anti-TNF therapy in these patients?
New answer by at Leiden University Medical Center (July 11, 2022)
In patients that failed standard conventional synthetic DMARD therapy and still have active disease, the start of a biological DMARD would be the next step. The choice is betw...